Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Stewart

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
European Heart Journal|September 10, 2013
Physical activity in patients with stable coronary heart disease: an international perspectiveRalph Stewart, Claes Held, Rebekkah Brown, et al.
Journal of the American College of Cardiology|October 22, 2013
Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease)Harvey D White, Andrew Tonkin, John Simes, et al.
Journal of the American College of Cardiology|May 6, 2014
Reply: the latest generation of troponin immunoassays: the "cholesterol" of the third millennium?Harvey D White, Andrew Tonkin, John Simes, et al.
The New Zealand Medical Journal|August 11, 2016
The All New Zealand Acute Coronary Syndrome Quality Improvement Programme: Implementation, Methodology and Cohorts (ANZACS-QI 9)Andrew Kerr, Michael Ja Williams, Harvey White, et al.
American Heart Journal|October 12, 2010
Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart diseaseHarvey White, Claes Held, Ralph Stewart, et al.
Resuscitation Plus|September 15, 2023
A study protocol for a cluster-randomised controlled trial of smartphone-activated first responders with ultraportable defibrillators in out-of-hospital cardiac arrest: The First Responder Shock Trial (FIRST)Verity Todd, Bridget Dicker, Daniel Okyere, et al.
Trials|January 27, 2018
Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trialRalph Maddison, Ralph Stewart, Rob Doughty, et al.
Cardiovascular Research|March 4, 2023
Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular diseasePia Davidsson, Susanna Eketjäll, Niclas Eriksson, et al.
Cardiology|August 28, 2025
The Prognostic Value of Cardiac Troponin in a Revascularized Cohort with First-time Myocardial InfarctionNikki J Earle, Katrina K Poppe, Anna P Pilbrow, et al.
International Journal of Cardiology|August 31, 2015
Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker studyAndrew M Tonkin, Stefan Blankenberg, Adrienne Kirby, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
European Heart Journal|September 10, 2013
Physical activity in patients with stable coronary heart disease: an international perspectiveRalph Stewart, Claes Held, Rebekkah Brown, et al.
Journal of the American College of Cardiology|October 22, 2013
Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease)Harvey D White, Andrew Tonkin, John Simes, et al.
Journal of the American College of Cardiology|May 6, 2014
Reply: the latest generation of troponin immunoassays: the "cholesterol" of the third millennium?Harvey D White, Andrew Tonkin, John Simes, et al.
The New Zealand Medical Journal|August 11, 2016
The All New Zealand Acute Coronary Syndrome Quality Improvement Programme: Implementation, Methodology and Cohorts (ANZACS-QI 9)Andrew Kerr, Michael Ja Williams, Harvey White, et al.
American Heart Journal|October 12, 2010
Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart diseaseHarvey White, Claes Held, Ralph Stewart, et al.
Resuscitation Plus|September 15, 2023
A study protocol for a cluster-randomised controlled trial of smartphone-activated first responders with ultraportable defibrillators in out-of-hospital cardiac arrest: The First Responder Shock Trial (FIRST)Verity Todd, Bridget Dicker, Daniel Okyere, et al.
Trials|January 27, 2018
Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trialRalph Maddison, Ralph Stewart, Rob Doughty, et al.
Cardiovascular Research|March 4, 2023
Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular diseasePia Davidsson, Susanna Eketjäll, Niclas Eriksson, et al.
Cardiology|August 28, 2025
The Prognostic Value of Cardiac Troponin in a Revascularized Cohort with First-time Myocardial InfarctionNikki J Earle, Katrina K Poppe, Anna P Pilbrow, et al.
International Journal of Cardiology|August 31, 2015
Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker studyAndrew M Tonkin, Stefan Blankenberg, Adrienne Kirby, et al.
Pageof 8